DexCom Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

DexCom Stock Summary

DexCom competes with Tandem Diabetes, Inspire Medical, Penumbra, Insulet, and Integra LifeSciences. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California. Dexcom operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 6300 people.

DexCom Key Financial Ratios

DexCom Key Balance Sheet Accounts

DexCom Key Income Statement Accounts

DexCom Key Cash Accounts

DexCom Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining DexCom's current stock value. Our valuation model uses many indicators to compare DexCom value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DexCom competition to find correlations between indicators driving DexCom's intrinsic value. More Info.DexCom Inc is rated # 2 in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.19  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DexCom Inc is roughly  5.29 . At this time, DexCom's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value DexCom by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

DexCom Inc Systematic Risk

Today, most investors in DexCom Stock are looking for potential investment opportunities by analyzing not only static indicators but also various DexCom's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of DexCom growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of DexCom help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DexCom Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of DexCom Inc based on widely used predictive technical indicators. In general, we focus on analyzing DexCom Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DexCom's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.